4.8 Article

A Novel Noninvasive Genotyping Method of Helicobacter pylori Using Stool Specimens

Journal

GASTROENTEROLOGY
Volume 135, Issue 5, Pages 1543-1551

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2008.08.006

Keywords

-

Ask authors/readers for more resources

Background & Aims: The source(s) of the infection and the route(s) of transmission of Helicobacter pylori have not yet been clarified. This is to introduce a noninvasive protocol allowing molecular typing of H pylori using stool specimens. Methods: The genotyping method is based on 2 H pylori-specific biprobe real-time polymerase chain reaction assays using fragments of the glmM and the recA genes as target sequences. Discrimination between strains results from differences in the melting temperature during melting curve analysis. In case of identical melting temperatures in both assays, sequence analysis of the glmM amplicon was performed to confirm strain identity. The method was validated using gastric biopsy specimens and stool specimens of 97 unrelated individuals suffering from abdominal pain and stool specimens of members of 10 families in Austria (infected index child and family members) and 8 African households. Results: Of the 97 patients, 27 were infected as shown by culture, histology, and rapid urease test. The sensitivity of each of the assays was 100% in gastric biopsy specimens and 92.2% in stool specimens; the specificity was 100%. The discriminatory capacity of the method was 100%. Clonal identities were found in 9 of 10 (90%) European and 7 of 8 (87.5%) African households. In 2 African households, 2 different clonal lineages each were found. Conclusions: The genotyping protocol introduced allows for both accurate detection and discrimination of H pylori strains in stool samples. Large-scale studies using this protocol may contribute to the clarification of the transmission pathways of infection with Hpylori.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Parasitology

Drug-induced hypersensitivity to artemisinin-based therapies for malaria

Tamara Nordmann, Steffen Borrmann, Michael Ramharter

Summary: Hypersensitivity to artemisinin derivatives is a medically important adverse drug reaction, but its frequency and underlying mechanisms are still unknown. It is suggested to provide alternative drugs for patients who cannot tolerate artemisinin derivatives and continue to develop novel non-artemisinin-based combination therapies.

TRENDS IN PARASITOLOGY (2022)

Article Immunology

Deciphering the Plasmodium falciparum malaria-specific CD4+T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+EXP1-specific CD4+T cells using a novel HLA-DR11-restricted MHC class II tetramer

Sophia Schulte, Janna Heide, Christin Ackermann, Sven Peine, Michael Ramharter, Maria Sophia Mackroth, Robin Woost, Thomas Jacobs, Julian Schulze Zur Wiesch

Summary: This study found that EXP1-specific CD4+ T cells had relatively low ex vivo frequency in malaria patients, with a distinct phenotype compared to bulk CD4+ T cells, showing a highly activated effector memory phenotype with elevated levels of co-inhibitory receptors and activation markers.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2022)

Article Immunology

T cells expressing multiple co-inhibitory molecules in acute malaria are not exhausted but exert a suppressive function in mice

Johannes Brandi, Cari Lehmann, Lea-Christina Kaminski, Julian Schulze Zur Wiesch, Marylyn Addo, Michael Ramharter, Maria Mackroth, Thomas Jacobs, Mathias Riehn

Summary: The overwhelming activation of T cells in acute malaria is associated with severe outcomes, but T cells expressing co-inhibitory molecules are not exhausted, and acquire additional suppressive capacity, representing a potential immune regulatory pathway to prevent further T cell activation during acute malaria.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Article Infectious Diseases

Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambarene, Gabon

Paulin N. Essone, Bayode R. Adegbite, Marien J. M. Mbadinga, Armel Mbouna, Fabrice Lotola-Mougeni, Ayodele Alabi, Jean R. Edoa, Bertrand Lell, Abraham S. Alabi, Ayola A. Adegnika, Michael Ramharter, Joel F. D. Siawaya, Martin P. Grobusch, Peter G. Kremsner, Selidji T. Agnandji

Summary: This study evaluated the diagnostic utility of creatine kinase-MB (CK-MB) and hepcidin (HEPC) for tuberculosis (TB) and found that their levels were statistically different between confirmed TB cases and non-TB cases. Combining them with two other biomarkers can improve the diagnostic accuracy.

INFECTION (2022)

Correction Immunology

Molecular Epidemiology of Mansonella Species in Gabon (vol 223, pg 287, 2021)

Thaisa Lucas Sandri, Andrea Kreidenweiss, Simon Cavallo, David Weber, Sascha Juhas, Miriam Rodi, Tamirat Gebru Woldearegai, Markus Gmeiner, Luzia Veletzky, Michael Ramharter, Gildas B. Tazemda-Kuitsouc, Pierre Blaise Matsiegui, Benjamin Mordmueller, Jana Held

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria

Quique Bassat, Oumou Maiga-Ascofare, Jurgen May, Jerome Clain, Ghyslain Mombo-Ngoma, Mirjam Groger, Ayola A. Adegnika, Jean-Claude Dejon Agobe, Abdoulaye Djimde, Johannes Mischlinger, Michael Ramharter

Summary: The triple artemisinin-based combination therapy (TACT) is a new treatment paradigm for uncomplicated falciparum malaria, which aims to prevent the development and spread of multidrug resistance more effectively than current artemisinin-based combination therapy (ACT). However, TACT is associated with a slightly higher frequency of adverse drug reactions compared to ACT. The challenge lies in evaluating efficacy and tolerability, and providing objective evidence for the management of patients and prevention of anti-malarial drug resistance by TACT.

MALARIA JOURNAL (2022)

Article Immunology

Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria

Mirjam Groger, Peter Akhideno, Christine J. Kleist, Femi O. Babatunde, Osahogie Edeawe, Julia Hinzmann, ThankGod Akhigbe, Joy Nwatuzor, Gloria Eifediyi, Jonas Mueller, Mette Hinrichs, Meike Pahlmann, Francisca Naana Sarpong, Christine Wagner, Anke Thielebein, Louis Aihonwalan, Till Koch, Maria Riedner, Ephraim Ogbaini-Emovon, Sylvanus Okogbenin, Stephan Guenther, Sebastian G. Wicha, Michael Ramharter, Lisa Oestereich, Sophie Duraffour, Cyril Erameh

Summary: This study examines the pharmacokinetics of ribavirin in the treatment of Lassa fever and finds consistent exposure across patients. While ribavirin shows low antiviral efficacy, it may have anti-inflammatory effects. Further research is needed to determine the role of ribavirin in the treatment of Lassa fever.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Impact of antibiotic intake on the incidence of extended-spectrum b-lactamase-producing Enterobacterales in sub-Saharan Africa: results from a community-based longitudinal study

Melina Heinemann, Lukas Kleinjohann, Thierry Rolling, Doris Winter, Nina Hackbarth, Michael Ramharter, Marylyn Addo, Daniel Eibach, Richard O. Phillips, Alex Owusu-Ofori, Christof D. Vinnemeier

Summary: This longitudinal study aimed to assess the impact of antibiotic intake on the incidence of intestinal extended-spectrum b-lactamase-producing Enterobacterales (ESBL-PE) in Ghanaian pharmacy customers outside of hospitals. The study found that the rate of intestinal ESBL-PE carriage among pharmacy customers increased during the 28 days of follow-up, regardless of antibiotic intake. This highlights the urgent need for improved prevention strategies, development of new antibiotic drugs, and potential future elimination strategies.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Infectious Diseases

Distinct loiasis infection states and associated clinical and hematological manifestations in patients from Gabon

Luzia Veletzky, Kirsten Alexandra Eberhardt, Jennifer Hergeth, Daniel Robert Stelzl, Rella Zoleko Manego, Ghyslain Mombo-Ngoma, Ruth Kreuzmair, Gerrit Burger, Ayola Akim Adegnika, Selidji Todagbe Agnandji, Pierre Blaise Matsiegui, Michel Boussinesq, Benjamin Mordmueller, Michael Ramharter

Summary: Loiasis, a filarial disease endemic in Central and West Africa, presents with varying clinical and hematological findings depending on the infection status. Eye worm positivity is associated with a wide range of clinical manifestations, while microfilaremia itself is not; Loa loa infection is correlated with eosinophilia.

PLOS NEGLECTED TROPICAL DISEASES (2022)

Article Infectious Diseases

Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambarene, Gabon: A non-randomised event-monitoring study

Rella Zoleko-Manego, Dearie G. Okwu, Christian Handrich, Lia B. Dimessa-Mbadinga, Malick A. Akinosho, Wilfrid F. Ndzebe-Ndoumba, Saskia D. Davi, Daniel Stelzl, Luzia Veletzky, Andrea Kreidenweiss, Tamara Nordmann, Ayola A. Adegnika, Bertrand Lell, Peter G. Kremsner, Michael Ramharter, Ghyslain Mombo-Ngoma

Summary: The first-line recommended artemisinin-based combination therapies (ACTs) and investigational second-generation ACTs used for the treatment of uncomplicated malaria were found to reduce the excretion of S. haematobium eggs in patients co-infected with urogenital schistosomiasis.

PLOS NEGLECTED TROPICAL DISEASES (2022)

Review Infectious Diseases

Alveolar echinococcosis in immunocompromised hosts

Brice Autier, Bruno Gottstein, Laurence Millon, Michael Ramharter, Beate Gruener, Solange Bresson-Hadni, Sarah Dion, Florence Robert-Gangneux

Summary: This narrative review examines the presentation of alveolar echinococcosis (AE) in immunocompromised patients and provides recommendations for patient management and future research. The findings indicate a significant association between AE and solid organ transplantation, chronic inflammatory/autoimmune diseases, and malignancies, but not HIV infection. AE in immunocompromised patients is characterized by early diagnosis, atypical imaging, and low sensitivity of serology.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Public, Environmental & Occupational Health

Symptoms of illness during travel and risk factors for non-adherence to malaria prophylaxis-a cross-sectional study in travellers from Germany

Friederike Reinsberg, Mary W. Moehlmann, Ralf Krumkamp, Lena Landsmann, Christian Heitkamp, Johannes Jochum, Marylyn Addo, Michael Ramharter, Christiane Radt, Camilla Rothe, Christof Vinnemeier, Benno Kreuels

Summary: This study investigated whether travelers who used antimalarial chemoprophylaxis experienced symptoms of illness and identified risk factors for non-adherence to prophylaxis. The results showed that the occurrence of symptoms during travel did not differ significantly between participants who used prophylaxis and those who did not. Risk factors for non-adherence to prophylaxis included being under the age of 30, traveling to West or Central Africa, and travel duration exceeding 14 days.

JOURNAL OF TRAVEL MEDICINE (2023)

Article Public, Environmental & Occupational Health

Rabies post-exposure prophylaxis of international travellers-Results from two major German travel clinics

Farah Saffar, Melina Heinemann, Christian Heitkamp, Daniel Robert Stelzl, Michael Ramharter, Mirjam Schunk, Camilla Rothe, Silja Buehler

Summary: This study aimed to assess the appropriateness of medical management following suspected rabies exposure (SRE) in international travellers. The results showed that awareness for appropriate first aid and timely seeking of professional treatment is insufficient in German travellers. Travel practitioners need to educate travellers about rabies risk, prevention measures, and the correct behavior after SRE including adequate wound treatment and seeking immediate medical help for prophylaxis.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2023)

Article Infectious Diseases

Focussed Assessment with Sonography in acute Lassa Fever (FASLa): Development of a point-of-care protocol and description of common ultrasound findings

Cyril O. Erameh, Till Koch, Osahogie Isaac Edeawe, Lisa Oestereich, Till Omansen, Johannes Jochum, Donatus I. Adomeh, Odia Ikponmwonsa, Chris Aire, Meike Pahlmann, Danny A. Asogun, Ephraim Ogbaini-Emovon, Sylvanus A. Okogbenin, Stephan Guenther, Michael Ramharter, Peter E. Akideno, Benno Kreuels

Summary: A study conducted at a hospital in Nigeria utilized POCUS technique to examine LF patients and found various pathological findings such as ascites, pericardial effusion, and pleural effusion. The use of POCUS required minimal resources and training, and it may help guide the clinical management of LF patients.

JOURNAL OF INFECTION (2023)

Article Medicine, General & Internal

Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults - a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trial

Dorothea Ekoka Mbassi, Ghyslain Mombo-Ngoma, Jana Held, Dearie Glory Okwu, Wilfrid Ndzebe-Ndoumba, Laura Charlotte Kalkman, Franck Aurelien Ekoka Mbassi, Lais Pessanha de Carvalho, Juliana Inoue, Malik Azeez Akinosho, Lia Betty Dimessa Mbadinga, Emmanuel Koffi Yovo, Benjamin Mordmueller, Peter Gottfried Kremsner, Ayola Akim Adegnika, Michael Ramharter, Rella Zoleko-Manego

Summary: This study assessed the tolerability and efficacy of ivermectin in Gabonese adults with P. falciparum infections. The results showed that ivermectin reduced the asexual parasites similarly to placebo, indicating its potential as a treatment for asymptomatic P. falciparum infections.

EBIOMEDICINE (2023)

No Data Available